American Analyst Updates: Nov 6th, 2026

Analyst Ratings (USA)

Wall Street analysts maintained a cautious and selective outlook, with nearly equal numbers of upward and downward price target revisions, although downgrades significantly outnumbered upgrades. Positive sentiment remained concentrated in select healthcare, semiconductor, energy, and technology companies, while software, utilities, consumer discretionary, and financial services faced increasing scrutiny. Overall, analysts continue to identify opportunities for growth but are becoming more conservative on valuations, earnings expectations, and company-specific risks, suggesting a mixed market outlook with heightened volatility and greater emphasis on earnings quality and financial fundamentals.

Updates ( 756)

10x Genomics (TXG): Citigroup raised its price target to $60.00 from $50.00 and assigned a Neutral rating.

10x Genomics (TXG): Stifel Nicolaus raised its price target to $68.00 from $50.00 and assigned a Buy rating.

10x Genomics (TXG): UBS Group lowered its price target to $61.00 from $90.00 and assigned a Neutral rating.

3D Systems (DDD): Craig Hallum downgraded the stock to Hold with a price target of $2.

Acadia Healthcare (ACHC): Cantor Fitzgerald raised its price target to $39.00 from $30.00 and assigned a Neutral rating.

Acadia Healthcare (ACHC): Guggenheim raised its price target to $41.00 from $39.00 and assigned a Buy rating.

Acadia Healthcare (ACHC): Royal Bank Of Canada raised its price target to $41.00 from $31.00 and assigned an Outperform rating.

ACADIA Pharmaceuticals (ACAD): Canaccord Genuity Group raised its price target to $38.00 from $36.00 and assigned a Buy rating.

ACI Worldwide (ACIW): Needham & Company LLC reiterated a Hold rating.

Adient (ADNT): Citigroup lowered its price target to $27.00 from $29.00 and assigned a Buy rating.

Advance Auto Parts (AAP): Evercore reiterated a Positive rating.

Advance Auto Parts (AAP): Mizuho set a price target of $50.00.

Advance Auto Parts (AAP): Royal Bank Of Canada reported a price-target increase and assigned an Outperform rating.

Advanced Drainage Systems (WMS): Barclays lowered its price target to $183.00 from $191.00 and assigned an Overweight rating.

Advanced Drainage Systems (WMS): DA Davidson lowered its price target to $180.00 from $190.00 and assigned a Buy rating.

Advanced Drainage Systems (WMS): Oppenheimer reiterated an Outperform rating and updated its price target to $180.00 from $185.00.

Advanced Drainage Systems (WMS): Royal Bank Of Canada lowered its price target to $163.00 from $170.00 and assigned an Outperform rating.

Affirm (AFRM): Bank of America reiterated a Buy rating with a $109.00 price target.

Affirm (AFRM): Barclays reiterated a Sector Outperform rating.

Affirm (AFRM): Barclays lowered its price target to $100.00 from $105.00 and assigned an Overweight rating.

Affirm (AFRM): Citizens Jmp reiterated a Market Outperform rating with a $85.00 price target.

Affirm (AFRM): Needham & Company LLC reiterated a Buy rating.

Affirm (AFRM): Piper Sandler lowered its price target to $105.00 from $115.00 and assigned an Overweight rating.

Affirm (AFRM): Royal Bank Of Canada lowered its price target to $83.00 from $96.00 and assigned a Sector Perform rating.

Affirm (AFRM): Scotiabank raised its price target to $97.00 from $95.00 and assigned a Sector Outperform rating.

Affirm (AFRM): Stephens lowered its price target to $80.00 from $90.00 and assigned an Equal Weight rating.

Agios Pharmaceuticals (AGIO): HC Wainwright raised its price target to $62.00 from $55.00 and assigned a Buy rating.

Agios Pharmaceuticals (AGIO): Truist Financial lowered its price target to $35.00 from $37.00 and assigned a Buy rating.

Air Products and Chemicals (APD): Barclays lowered its price target to $346.00 from $353.00 and assigned an Overweight rating.

Air Products and Chemicals (APD): Royal Bank Of Canada raised its price target to $359.00 from $346.00 and assigned an Outperform rating.

Airbnb (ABNB): B. Riley Financial reiterated a Buy rating and updated its price target to $230.00 from $210.00.

Airbnb (ABNB): Barclays raised its price target to $195.00 from $150.00 and assigned an Equal Weight rating.

Airbnb (ABNB): Canaccord Genuity Group raised its price target to $225.00 from $200.00 and assigned a Buy rating.

Airbnb (ABNB): Cantor Fitzgerald raised its price target to $180.00 from $160.00 and assigned a Neutral rating.

Airbnb (ABNB): Citigroup raised its price target to $227.00 from $193.00 and assigned a Buy rating.

Airbnb (ABNB): Evercore reiterated an Outperform rating with a $230.00 price target.

Airbnb (ABNB): JPMorgan Chase & Co. raised its price target to $202.00 from $170.00 and assigned a Neutral rating.

Airbnb (ABNB): Mizuho set a price target of $245.00.

Airbnb (ABNB): Oppenheimer raised its price target to $230.00 from $210.00 and assigned an Outperform rating.

Airbnb (ABNB): Piper Sandler reiterated a Neutral rating and updated its price target to $180.00 from $170.00.

Airbnb (ABNB): Rosenblatt Securities raised its price target to $230.00 from $220.00 and assigned a Buy rating.

Airbnb (ABNB): Royal Bank Of Canada raised its price target to $215.00 from $195.00 and assigned an Outperform rating.

Airbnb (ABNB): Susquehanna raised its price target to $220.00 from $200.00 and assigned a Positive rating.

Airbnb (ABNB): The Goldman Sachs Group reiterated a Neutral rating with a $185.00 price target.

Airbnb (ABNB): Wedbush raised its price target to $237.00 from $200.00 and assigned an Outperform rating.

Airbnb (ABNB): Wells Fargo & Company raised its price target to $215.00 from $185.00 and assigned an Overweight rating.

Akamai Technologies (AKAM): DA Davidson lowered its price target to $125.00 from $150.00 and assigned a Buy rating.

Akamai Technologies (AKAM): Evercore reiterated an Outperform rating with a $150.00 price target.

Akamai Technologies (AKAM): FBN Securities reiterated an Outperform rating with a $120.00 price target.

Akamai Technologies (AKAM): KeyCorp lowered its price target to $175.00 from $195.00 and assigned an Overweight rating.

Akamai Technologies (AKAM): Piper Sandler reiterated an Overweight rating.

Akamai Technologies (AKAM): Royal Bank Of Canada lowered its price target to $85.00 from $135.00 and assigned a Sector Perform rating.

Akamai Technologies (AKAM): Scotiabank lowered its price target to $120.00 from $180.00 and assigned a Sector Outperform rating.

Akamai Technologies (AKAM): Susquehanna lowered its price target to $90.00 from $140.00 and assigned a Positive rating.

Akamai Technologies (AKAM): UBS Group lowered its price target to $90.00 from $100.00 and assigned a Neutral rating.

Alarm.com (ALRM): Barclays raised its price target to $70.00 from $60.00 and assigned an Equal Weight rating.

Alarm.com (ALRM): William Blair reiterated a Market Perform rating.

Albemarle (ALB): Barclays lowered its price target to $95.00 from $109.00 and assigned an Equal Weight rating.

Albemarle (ALB): Royal Bank Of Canada lowered its price target to $119.00 from $129.00 and assigned an Outperform rating.

Albemarle (ALB): Truist Financial reiterated a Buy rating and updated its price target to $170.00 from $185.00.

Allied Gold Corporation (AAUC): National Bank Financial upgraded the stock to Outperform.

Allison Transmission (ALSN): Subscribe to MarketBeat All Access to unlock brokerage rankings raised its price target to $147.00 from $144.00 and assigned a Buy rating.

Allison Transmission (ALSN): Wolfe Research set a price target of $147.00.

Allstate (ALL): Citigroup raised its price target to $225.00 from $215.00 and assigned a Sell rating.

Allstate (ALL): HSBC downgraded the stock to Hold with a price target of $271.

Allstate (ALL): Wells Fargo & Company raised its price target to $252.00 from $236.00 and assigned an Equal Weight rating.

Alpha and Omega Semiconductor (AOSL): B. Riley Financial lowered its price target to $22.00 from $25.00 and assigned a Neutral rating.

Alpha and Omega Semiconductor (AOSL): Needham & Company LLC lowered its price target to $30.00 from $45.00 and assigned a Buy rating.

Alpha and Omega Semiconductor (AOSL): Stifel Nicolaus lowered its price target to $27.00 from $34.00 and assigned a Hold rating.

AMC Entertainment (AMC): Citigroup raised its price target to $2.60 from $2.20 and assigned a Sell rating.

American Homes 4 Rent (AMH): Royal Bank Of Canada raised its price target to $36.00 from $35.00 and assigned an Outperform rating.

American Homes 4 Rent (AMH): Truist Financial set a price target of $45.00.

American Homes 4 Rent (AMH): Zelman & Associates upgraded the stock to Neutral.

American States Water (AWR): Subscribe to MarketBeat All Access to unlock brokerage rankings upgraded the stock to Buy with a price target of $99.00.

American Superconductor (AMSC): Oppenheimer lowered its price target to $52.00 from $71.00 and assigned an Outperform rating.

American Water Works (AWK): UBS Group downgraded the stock to Neutral with a price target of $162.

Amgen (AMGN): Subscribe to MarketBeat All Access to unlock brokerage rankings downgraded the stock to Hold with a price target of $470.00.

AMN Healthcare Services (AMN): Bank of America reiterated an Underperform rating.

AMN Healthcare Services (AMN): Citizens Jmp raised its price target to $51.00 from $40.00 and assigned a Market Outperform rating.

Amphastar Pharmaceuticals (AMPH): Wells Fargo & Company raised its price target to $25.00 from $20.00 and assigned an Equal Weight rating.

Amplitude (AMPL): Citigroup raised its price target to $18.00 from $11.00 and assigned a Neutral rating.

Amprius Technologies (AMPX): UBS Group reiterated an Outperform rating.

Amprius Technologies (AMPX): William Blair reiterated an Outperform rating.

ANI Pharmaceuticals (ANIP): Guggenheim raised its price target to $121.00 from $119.00 and assigned a Buy rating.

Apollo Global Management (APO): Argus lowered its price target to $140.00 from $160.00 and assigned a Buy rating.

Appian (APPN): Citigroup raised its price target to $69.00 from $40.00 and assigned a Buy rating.

Appian (APPN): DA Davidson raised its price target to $60.00 from $42.00 and assigned a Neutral rating.

Applied Optoelectronics (AAOI): B. Riley Financial lowered its price target to $45.00 from $92.00 and assigned a Neutral rating.

Applied Optoelectronics (AAOI): Needham & Company LLC lowered its price target to $100.00 from $170.00 and assigned a Buy rating.

Applied Optoelectronics (AAOI): Rosenblatt Securities lowered its price target to $115.00 from $220.00 and assigned a Buy rating.

AppLovin (APP): Wells Fargo & Company raised its price target to $347.00 from $325.00 and assigned an Equal Weight rating.

Aptiv (APTV): Citigroup lowered its price target to $68.00 from $77.00 and assigned a Buy rating.

Ardent Health (ARDT): Royal Bank Of Canada raised its price target to $18.00 from $13.00 and assigned an Outperform rating.

Ardent Health (ARDT): Stephens raised its price target to $21.00 from $13.00 and assigned an Overweight rating.

Arlo Technologies (ARLO): Piper Sandler reiterated an Overweight rating and updated its price target to $17.00 from $16.00.

Arrow Electronics (ARW): Truist Financial lowered its price target to $230.00 from $250.00 and assigned a Buy rating.

ARS Pharmaceuticals (SPRY): Raymond James Financial downgraded the stock to Outperform with a price target of $17.

Arteris (AIP): Jefferies Financial Group lowered its price target to $40.00 from $50.00 and assigned a Buy rating.

Artivion (AORT): Canaccord Genuity Group lowered its price target to $30.00 from $40.00 and assigned a Buy rating.

Artivion (AORT): Citizens Jmp lowered its price target to $42.00 from $48.00 and assigned a Market Outperform rating.

ASOS (ASC): Deutsche Bank Aktiengesellschaft raised its price target to GBX 490 from GBX 450 and assigned a Buy rating.

Astrana Health (ASTH): Needham & Company LLC raised its price target to $45.00 from $41.00 and assigned a Buy rating.

Atlanticus (ATLC): BTIG Research lowered its price target to $150.00 from $179.00 and assigned a Buy rating.

Atlassian (TEAM): BTIG Research lowered its price target to $240.00 from $260.00 and assigned a Buy rating.

Atlassian (TEAM): Guggenheim set a price target of $280.00.

Atlassian (TEAM): Jefferies Financial Group lowered its price target to $190.00 from $245.00 and assigned a Buy rating.

Atlassian (TEAM): Oppenheimer lowered its price target to $240.00 from $275.00 and assigned an Outperform rating.

Atlassian (TEAM): Piper Sandler raised its price target to $190.00 from $175.00 and assigned an Overweight rating.

Atlassian (TEAM): Truist Financial reiterated a Buy rating and updated its price target to $200.00 from $250.00.

Atlassian (TEAM): UBS Group reiterated a Buy rating.

Atlassian (TEAM): Wells Fargo & Company lowered its price target to $200.00 from $270.00 and assigned an Overweight rating.

Atmos Energy (ATO): Wells Fargo & Company reiterated an Overweight rating with a $201.00 price target.

aTyr Pharma (ATYR): Royal Bank Of Canada lowered its price target to $6.00 and assigned a Sector Perform rating.

aTyr Pharma (ATYR): Wells Fargo & Company raised its price target to $4.00 from $1.00 and assigned an Equal Weight rating.

Auto Trader Group (AUTO): Deutsche Bank Aktiengesellschaft reiterated a Buy rating with a GBX 794 price target.

Autodesk (ADSK): Oppenheimer reiterated an Outperform rating.

Avalo Therapeutics (AVTX): Wedbush lowered its price target to $20.00 from $22.00 and assigned an Outperform rating.

AvePoint (AVPT): Cantor Fitzgerald raised its price target to $19.00 from $15.00 and assigned an Overweight rating.

AvePoint (AVPT): Scotiabank raised its price target to $20.00 from $15.00 and assigned a Sector Outperform rating.

Avita Medical (RCEL): BTIG Research raised its price target to $21.00 from $15.00 and assigned a Buy rating.

Axcelis Technologies (ACLS): B. Riley Financial reiterated a Buy rating and updated its price target to $140.00 from $165.00.

Axcelis Technologies (ACLS): Craig Hallum upgraded the stock to Buy with a price target of $140.

Axon Enterprise (AXON): Craig Hallum downgraded the stock to Hold with a price target of $390.

Axon Enterprise (AXON): Needham & Company LLC lowered its price target to $500.00 from $750.00 and assigned a Buy rating.

Axon Enterprise (AXON): Northland Securities set a price target of $540.00.

Axon Enterprise (AXON): Piper Sandler reiterated an Overweight rating and updated its price target to $540.00 from $561.00.

Axon Enterprise (AXON): Royal Bank Of Canada lowered its price target to $615.00 from $735.00 and assigned an Outperform rating.

Becton Dickinson (BDX): Wells Fargo upgraded the stock to Overweight with a price target of $242.

Becton, Dickinson and Company (BDX): Citigroup raised its price target to $241.00 from $208.00 and assigned a Buy rating.

Becton, Dickinson and Company (BDX): Piper Sandler raised its price target to $200.00 from $175.00 and assigned a Neutral rating.

Becton, Dickinson and Company (BDX): Royal Bank Of Canada raised its price target to $225.00 from $190.00 and assigned a Sector Perform rating.

Bentley Systems (BSY): Cantor Fitzgerald raised its price target to $55.00 from $42.00 and assigned an Overweight rating.

Bentley Systems (BSY): Oppenheimer raised its price target to $52.00 from $43.00 and assigned an Outperform rating.

Bentley Systems (BSY): Rosenblatt Securities raised its price target to $53.00 from $50.00 and assigned a Buy rating.

Bentley Systems (BSY): Royal Bank Of Canada raised its price target to $52.00 from $48.00 and assigned an Outperform rating.

BeOne Medicines (ONC): Barclays raised its price target to $446.00 from $415.00 and assigned an Overweight rating.

BeOne Medicines (ONC): Citizens Jmp raised its price target to $463.00 from $405.00 and assigned a Market Outperform rating.

BeOne Medicines (ONC): Royal Bank Of Canada raised its price target to $465.00 from $459.00 and assigned an Outperform rating.

BeOne Medicines (ONC): Truist Financial reiterated a Buy rating and updated its price target to $448.00 from $420.00.

BeOne Medicines (ONC): Wells Fargo & Company raised its price target to $435.00 from $400.00 and assigned an Overweight rating.

Best Buy (BBY): Citigroup raised its price target to $102.00 from $88.00 and assigned a Neutral rating.

Best Buy (BBY): Wells Fargo & Company raised its price target to $95.00 from $85.00 and assigned an Equal Weight rating.

BETA Technologies (BETA): BTIG Research reiterated a Buy rating with a $33.00 price target.

BILL (BILL): Keefe, Bruyette & Woods raised its price target to $58.00 from $52.00 and assigned a Market Perform rating.

BILL (BILL): Oppenheimer raised its price target to $60.00 from $55.00 and assigned an Outperform rating.

BJ’s Wholesale Club (BJ): Citigroup downgraded the stock to Neutral with a price target of $113.

Black Hills (BKH): Scotiabank raised its price target to $95.00 from $84.00 and assigned a Sector Outperform rating.

BlackLine (BL): Piper Sandler lowered its price target to $30.00 from $35.00 and assigned a Neutral rating.

Blend Labs (BLND): Citizens Jmp lowered its price target to $2.50 from $4.00 and assigned a Market Outperform rating.

Blend Labs (BLND): Wells Fargo & Company lowered its price target to $2.00 from $3.00 and assigned an Overweight rating.

Blink Charging (BLNK): Needham & Company LLC reiterated a Hold rating.

Blue Owl Technology Finance (OTF): Wells Fargo & Company lowered its price target to $11.00 from $12.00 and assigned an Overweight rating.

Bob’s Discount Furniture (BOBS): Royal Bank Of Canada lowered its price target to $21.00 from $22.00 and assigned an Outperform rating.

Brookfield Business (BBUC): Royal Bank Of Canada downgraded the stock to Sector Perform with a price target of $34.00.

BT Group (BT.A): Deutsche Bank Aktiengesellschaft reiterated a Sell rating with a GBX 150 price target.

C4 Therapeutics (CCCC): Guggenheim lowered its price target to $6.00 from $7.00 and assigned a Buy rating.

Cardinal Health (CAH): Royal Bank Of Canada raised its price target to $295.00 from $276.00 and assigned an Outperform rating.

CarGurus (CARG): Royal Bank Of Canada lowered its price target to $41.00 from $42.00 and assigned an Outperform rating.

Caris Life Sciences (CAI): Citigroup raised its price target to $36.00 from $28.00 and assigned a Buy rating.

Carlyle Group (CG): Barclays lowered its price target to $48.00 from $53.00 and assigned an Overweight rating.

Carlyle Group (CG): Evercore set a price target of $42.00.

Carriage Services (CSV): B. Riley Financial lowered its price target to $56.00 from $65.00 and assigned a Buy rating.

Carriage Services (CSV): The Goldman Sachs Group set a price target of $56.00.

Carriage Services (CSV): UBS Group set a price target of $56.00.

Cars.com (CARS): B. Riley Financial raised its price target to $15.00 from $13.00 and assigned a Neutral rating.

Castle Biosciences (CSTL): KeyCorp raised its price target to $40.00 from $35.00 and assigned an Overweight rating.

CAVA Group (CAVA): Citigroup lowered its price target to $65.00 from $66.00 and assigned a Neutral rating.

Celcuity (CELC): Guggenheim lowered its price target to $169.00 from $171.00 and assigned a Buy rating.

Celsius (CELH): B. Riley Financial reiterated a Buy rating and updated its price target to $53.00 from $56.00.

Celsius (CELH): Needham & Company LLC raised its price target to $40.00 from $35.00 and assigned a Buy rating.

Celsius (CELH): Stifel Nicolaus set a price target of $36.00.

Centrus Energy (LEU): Barclays lowered its price target to $149.00 from $150.00 and assigned an Equal Weight rating.

Centrus Energy (LEU): Roth Capital upgraded the stock to Buy with a price target of $115.

Centuri (CTRI): Wells Fargo & Company lowered its price target to $24.00 from $28.00 and assigned an Overweight rating.

Century Aluminum (CENX): Wells Fargo & Company lowered its price target to $71.00 from $79.00 and assigned an Overweight rating.

Certara (CERT): Barclays raised its price target to $12.00 from $9.00 and assigned an Equal Weight rating.

Certara (CERT): Jefferies Financial Group reiterated a Hold rating with a $12.00 price target.

Certara (CERT): UBS Group reiterated a Neutral rating with a $13.00 price target.

Chord Energy (CHRD): Truist Financial raised its price target to $197.00 from $195.00 and assigned a Buy rating.

Chord Energy (CHRD): Wells Fargo & Company lowered its price target to $173.00 from $174.00 and assigned an Overweight rating.

Cigna Group (CI): Cantor Fitzgerald reiterated an Overweight rating with a $340.00 price target.

Cigna Group (CI): Guggenheim lowered its price target to $347.00 from $361.00 and assigned a Buy rating.

Cimpress (CMPR): Barrington Research lowered its price target to $102.00 from $121.00 and assigned an Outperform rating.

Cloudflare (NET): Cantor Fitzgerald lowered its price target to $310.00 from $340.00 and assigned a Neutral rating.

Cloudflare (NET): Guggenheim raised its price target to $190.00 from $160.00 and assigned a Buy rating.

Cloudflare (NET): Jefferies Financial Group lowered its price target to $315.00 from $320.00 and assigned a Hold rating.

Cloudflare (NET): Needham & Company LLC lowered its price target to $365.00 from $380.00 and assigned a Buy rating.

Cloudflare (NET): Piper Sandler reiterated an Overweight rating and updated its price target to $337.00 from $333.00.

Cloudflare (NET): Royal Bank Of Canada lowered its price target to $350.00 from $405.00 and assigned an Outperform rating.

Cloudflare (NET): Scotiabank lowered its price target to $360.00 from $390.00 and assigned a Sector Outperform rating.

Cloudflare (NET): The Goldman Sachs Group set a price target of $420.00 with a Buy rating.

Cloudflare (NET): Wolfe Research upgraded the stock to Outperform.

Cogent Communications (CCOI): KeyCorp downgraded the stock to Sector Weight.

Cognex (CGNX): KeyCorp lowered its price target to $65.00 from $80.00 and assigned an Overweight rating.

Cognex (CGNX): Needham & Company LLC lowered its price target to $70.00 from $80.00 and assigned a Buy rating.

Cognex (CGNX): Stephens lowered its price target to $70.00 from $85.00 and assigned an Overweight rating.

Cognex (CGNX): Truist Financial lowered its price target to $57.00 from $74.00 and assigned a Hold rating.

Coinbase Global (COIN): Subscribe to MarketBeat All Access to unlock brokerage rankings lowered its price target to $175.00 from $185.00 and assigned a Buy rating.

Collegium Pharmaceutical (COLL): Jefferies Financial Group reiterated a Buy rating with a $35.00 price target.

Collegium Pharmaceutical (COLL): Piper Sandler lowered its price target to $28.00 from $43.00 and assigned a Neutral rating.

Compass (COMP): Barclays lowered its price target to $14.00 from $16.00 and assigned an Overweight rating.

Compass (COMP): BTIG Research lowered its price target to $13.00 from $15.00 and assigned a Buy rating.

Compass (COMP): Wells Fargo & Company lowered its price target to $9.00 from $10.00 and assigned an Equal Weight rating.

Comstock Resources (CRK): Truist Financial reiterated a Hold rating and updated its price target to $15.00 from $16.00.

Conduit (CRE): Berenberg Bank reiterated a Buy rating with a GBX 765 price target.

ConocoPhillips (COP): Wells Fargo & Company lowered its price target to $185.00 from $189.00 and assigned an Overweight rating.

Consolidated Edison (ED): Barclays raised its price target to $108.00 from $106.00 and assigned an Underweight rating.

Consolidated Edison (ED): Wells Fargo & Company raised its price target to $134.00 from $118.00 and assigned an Overweight rating.

Construction Partners (ROAD): Raymond James Financial reiterated a Strong-Buy rating with a $125.00 price target.

Construction Partners (ROAD): Truist Financial lowered its price target to $90.00 from $130.00 and assigned a Hold rating.

Core Scientific (CORZ): Craig Hallum reiterated a Buy rating with a $25.00 price target.

Core Scientific (CORZ): Needham & Company LLC lowered its price target to $28.00 from $35.00 and assigned a Buy rating.

Corsair Gaming (CRSR): Barclays lowered its price target to $14.00 from $15.00 and assigned an Overweight rating.

Coty (COTY): Royal Bank Of Canada raised its price target to $3.50 from $3.00 and assigned a Sector Perform rating.

CRH (CRH): Wells Fargo & Company raised its price target to $107.00 from $100.00 and assigned an Overweight rating.

Croda International (CRDA): Berenberg Bank raised its price target to GBX 4,400 from GBX 3,600 and assigned a Buy rating.

Croda International (CRDA): Deutsche Bank Aktiengesellschaft reiterated a Hold rating with a GBX 3,300 price target.

CryoPort (CYRX): KeyCorp raised its price target to $20.00 from $17.00 and assigned an Overweight rating.

CryoPort (CYRX): Needham & Company LLC raised its price target to $28.00 from $19.00 and assigned a Buy rating.

CTO Realty Growth (CTO): Cantor Fitzgerald lowered its price target to $23.00 from $25.00 and assigned an Overweight rating.

Cummins (CMI): Citigroup lowered its price target to $525.00 from $630.00 and assigned a Buy rating.

Cummins (CMI): Truist Financial lowered its price target to $637.00 from $779.00 and assigned a Buy rating.

Cummins (CMI): Wells Fargo & Company lowered its price target to $520.00 from $608.00 and assigned an Overweight rating.

Curtiss-Wright (CW): Guggenheim lowered its price target to $674.00 from $786.00 and assigned a Buy rating.

Curtiss-Wright (CW): Piper Sandler lowered its price target to $544.00 from $586.00 and assigned a Neutral rating.

CVRx (CVRX): Canaccord Genuity Group downgraded the stock to Hold with a price target of $2.

CVRx (CVRX): William Blair downgraded the stock to Market Perform.

CVS Health (CVS): Raymond James Financial set a price target of $103.00.

CytomX Therapeutics (CTMX): Wedbush raised its price target to $12.00 from $11.00 and assigned an Outperform rating.

Damora Therapeutics, Inc. Common Stock (DMRA): Guggenheim lowered its price target to $59.00 from $60.00 and assigned a Buy rating.

Dave (DAVE): Keefe, Bruyette & Woods reiterated an Outperform rating.

Dave (DAVE): Royal Bank Of Canada set a price target of $380.00.

Delek US (DK): Raymond James Financial reiterated an Outperform rating with a $95.00 price target.

DENTSPLY SIRONA (XRAY): Bank of America reiterated a Buy rating.

Devon Energy (DVN): Barclays lowered its price target to $57.00 from $60.00 and assigned an Overweight rating.

Diageo (DGE): Berenberg Bank reiterated a Buy rating with a GBX 2,223 price target.

Diageo (DGE): Deutsche Bank Aktiengesellschaft raised its price target to GBX 1,740 from GBX 1,734 and assigned a Hold rating.

Diodes (DIOD): Needham & Company LLC lowered its price target to $100.00 from $110.00 and assigned a Buy rating.

Disc Medicine (IRON): HC Wainwright raised its price target to $127.00 from $120.00 and assigned a Buy rating.

DNOW (DNOW): Susquehanna lowered its price target to $18.00 from $19.00 and assigned a Positive rating.

Docebo (DCBO): Needham & Company LLC raised its price target to $42.00 from $31.00 and assigned a Buy rating.

DoorDash (DASH): Rosenblatt Securities lowered its price target to $225.00 from $270.00 and assigned a Buy rating.

Doximity (DOCS): Canaccord Genuity Group raised its price target to $40.00 from $36.00 and assigned a Buy rating.

Doximity (DOCS): Needham & Company LLC reiterated a Buy rating with a $41.00 price target.

Doximity (DOCS): Royal Bank Of Canada raised its price target to $34.00 from $28.00 and assigned an Outperform rating.

DraftKings (DKNG): Bank of America reiterated a Buy rating.

Dropbox (DBX): Royal Bank Of Canada raised its price target to $48.00 from $42.00 and assigned an Outperform rating.

Dropbox (DBX): UBS Group raised its price target to $26.00 from $23.00 and assigned a Sell rating.

Ducommun (DCO): B. Riley Financial lowered its price target to $203.00 from $222.00 and assigned a Buy rating.

Ducommun (DCO): Royal Bank Of Canada lowered its price target to $155.00 from $180.00 and assigned a Sector Perform rating.

Dutch Bros (BROS): Citigroup lowered its price target to $64.00 from $69.00 and assigned a Buy rating.

Eagle Materials (EXP): Citigroup raised its price target to $214.00 from $190.00 and assigned a Neutral rating.

Eagle Materials (EXP): Stephens raised its price target to $200.00 from $190.00 and assigned an Equal Weight rating.

Ecovyst (ECVT): BMO Capital Markets reiterated an Outperform rating.

eEnergy Group (EAAS): Canaccord Genuity Group lowered its price target to GBX 0.90 and assigned a Buy rating.

Energy Transfer (ET): Citigroup raised its price target to $25.00 from $24.00 and assigned a Buy rating.

Enliven Therapeutics (ELVN): Guggenheim reiterated a Buy rating with a $78.00 price target.

Enovis (ENOV): Canaccord Genuity Group lowered its price target to $42.00 from $45.00 and assigned a Buy rating.

Enovis (ENOV): Wells Fargo & Company raised its price target to $37.00 from $33.00 and assigned an Overweight rating.

EOG Resources (EOG): Barclays raised its price target to $155.00 from $147.00 and assigned an Equal Weight rating.

EOG Resources (EOG): Truist Financial set a price target of $166.00.

EPAM Systems (EPAM): Guggenheim raised its price target to $190.00 from $160.00 and assigned a Buy rating.

EPAM Systems (EPAM): Susquehanna raised its price target to $190.00 from $146.00 and assigned a Positive rating.

EPAM Systems (EPAM): Truist Financial raised its price target to $150.00 from $110.00 and assigned a Hold rating.

EPAM Systems (EPAM): Wedbush raised its price target to $160.00 from $99.00 and assigned a Neutral rating.

EPAM Systems (EPAM): Wells Fargo & Company raised its price target to $176.00 from $156.00 and assigned an Overweight rating.

EPR Properties (EPR): Truist Financial raised its price target to $65.00 from $61.00 and assigned a Hold rating.

Equinor ASA (EQNR): Morgan Stanley downgraded the stock to Underweight.

Essential Utilities (WTRG): UBS downgraded the stock to Neutral with a price target of $49.

Eton Pharmaceuticals (ETON): Canaccord Genuity Group raised its price target to $80.00 from $68.00 and assigned a Buy rating.

Eton Pharmaceuticals (ETON): HC Wainwright raised its price target to $80.00 from $70.00 and assigned a Buy rating.

EVE (EVEX): Canaccord Genuity Group lowered its price target to $7.00 from $7.50 and assigned a Buy rating.

EverCommerce (EVCM): Canaccord Genuity Group lowered its price target to $9.00 from $13.00 and assigned a Buy rating.

EverCommerce (EVCM): Deutsche Bank Aktiengesellschaft downgraded the stock to Hold with a price target of $7.

EverCommerce (EVCM): Oppenheimer lowered its price target to $11.00 from $13.00 and assigned an Outperform rating.

EverCommerce (EVCM): Royal Bank Of Canada lowered its price target to $7.00 from $10.00 and assigned a Sector Perform rating.

Eversource Energy (ES): Barclays initiated coverage with an Equal Weight rating and a $76.00 price target.

Eversource Energy (ES): Barclays resumed coverage with an Equal Weight rating and a $76 price target.

Evolent Health (EVH): Oppenheimer raised its price target to $7.00 from $6.00 and assigned an Outperform rating.

Evotec (EVO): HC Wainwright raised its price target to $5.00 from $4.00 and assigned a Buy rating.

Expedia Group (EXPE): Citigroup lowered its price target to $330.00 from $345.00 and assigned a Neutral rating.

Expedia Group (EXPE): Susquehanna lowered its price target to $310.00 from $315.00 and assigned a Neutral rating.

ExxonMobil (XOM): Subscribe to MarketBeat All Access to unlock brokerage rankings raised its price target to $162.00 from $142.00 and assigned a Hold rating.

Exzeo Group (XZO): William Blair reiterated an Outperform rating.

FactSet Research Systems (FDS): Barclays raised its price target to $305.00 from $250.00 and assigned an Underweight rating.

Fair Isaac (FICO): Mizuho set a price target of $901.00.

Fastly (FSLY): Citigroup lowered its price target to $25.00 from $27.00 and assigned a Neutral rating.

Fate Therapeutics (FATE): Wells Fargo & Company lowered its price target to $3.00 from $3.50 and assigned an Equal Weight rating.

Ferroglobe (GSM): Jefferies Financial Group set a price target of $5.00.

Ferroglobe (GSM): Needham & Company LLC set a price target of $5.00.

Fervo Energy (FRVO): Needham & Company LLC initiated coverage with a Buy rating and a $17 price target.

Fidelity National Information Services (FIS): Argus downgraded the stock to Hold.

Figma (FIG): Citigroup lowered its price target to $34.00 from $35.00 and assigned a Buy rating.

FIGS (FIGS): KeyCorp raised its price target to $27.00 from $20.00 and assigned an Overweight rating.

Firefly Aerospace (FLY): Jefferies Financial Group reiterated a Buy rating.

First Advantage (FA): Barclays raised its price target to $34.00 from $30.00 and assigned an Overweight rating.

First Advantage (FA): Jefferies Financial Group reiterated a Hold rating with a $26.00 price target.

First Advantage (FA): Needham & Company LLC raised its price target to $30.00 from $28.00 and assigned a Buy rating.

First Majestic Silver (AG): HC Wainwright lowered its price target to $25.00 from $25.50 and assigned a Buy rating.

First Watch Restaurant Group (FWRG): Guggenheim raised its price target to $21.00 from $20.00 and assigned a Buy rating.

Five9 (FIVN): Barclays lowered its price target to $38.00 from $40.00 and assigned an Overweight rating.

Five9 (FIVN): DA Davidson lowered its price target to $30.00 from $33.00 and assigned a Neutral rating.

Five9 (FIVN): Evercore downgraded the stock to In-line with a price target of $24.

Five9 (FIVN): KeyCorp raised its price target to $34.00 from $32.00 and assigned an Overweight rating.

Five9 (FIVN): Needham & Company LLC reiterated a Buy rating.

Five9 (FIVN): Truist Financial lowered its price target to $35.00 from $40.00 and assigned a Buy rating.

Five9 (FIVN): Wells Fargo & Company lowered its price target to $28.00 from $36.00 and assigned an Equal Weight rating.

Forgent Power Solutions (FPS): Roth Capital initiated coverage with a Buy rating.

Fortis (FTS): Barclays downgraded the stock to Equal Weight with a price target of $61.

Fortune Brands Innovations (FBIN): Citigroup raised its price target to $56.00 from $48.00 and assigned a Buy rating.

Frontdoor (FTDR): Truist Financial raised its price target to $115.00 from $105.00 and assigned a Buy rating.

FrontView REIT (FVR): JonesTrading lowered its price target to $20.00 from $21.00 and assigned a Buy rating.

FTAI Infrastructure (FIP): BTIG Research lowered its price target to $8.00 from $9.00 and assigned a Buy rating.

FTAI Infrastructure (FIP): UBS Group reiterated a Buy rating.

Full House Resorts (FLL): Citizens Jmp lowered its price target to $2.00 from $3.00 and assigned a Market Outperform rating.

Gartner (IT): Barclays downgraded the stock to Underweight with a price target of $185.

Genius Sports (GENI): Guggenheim raised its price target to $13.00 from $12.00 and assigned a Buy rating.

Genius Sports (GENI): Oppenheimer lowered its price target to $10.00 from $12.00 and assigned an Outperform rating.

Genius Sports (GENI): The Goldman Sachs Group reiterated a Buy rating with a $9.00 price target.

Genpact (G): Needham & Company LLC raised its price target to $55.00 from $45.00 and assigned a Buy rating.

Genpact (G): Susquehanna raised its price target to $42.00 from $40.00 and assigned a Neutral rating.

Gildan Activewear (GIL): Canaccord Genuity Group downgraded the stock to Hold with a price target of $41.00.

Gildan Activewear (GIL): Royal Bank Of Canada lowered its price target to $50.00 from $70.00 and assigned an Outperform rating.

Gildan Activewear (GIL): Scotiabank downgraded the stock to Sector Perform with a price target of $39.

Gildan Activewear (GIL): TD Cowen reiterated a Buy rating.

Gildan Activewear (GIL): UBS downgraded the stock to Neutral with a price target of $38.

Gildan Activewear (GIL): UBS Group set a price target of $38.00 with a Neutral rating.

Gildan Activewear (GIL): William Blair set a price target of $49.00.

Global Net Lease (GNL): Cantor Fitzgerald lowered its price target to $9.00 from $11.00 and assigned an Overweight rating.

Global Payments (GPN): Bank of America reiterated a Buy rating.

Global Payments (GPN): KeyCorp raised its price target to $112.00 from $105.00 and assigned an Overweight rating.

Global Payments (GPN): Wells Fargo & Company raised its price target to $116.00 from $103.00 and assigned an Overweight rating.

Globus Medical (GMED): BMO Capital Markets downgraded the stock to Market Perform with a price target of $78.

Globus Medical (GMED): BTIG Research reiterated a Neutral rating.

Globus Medical (GMED): Canaccord Genuity Group lowered its price target to $105.00 from $115.00 and assigned a Buy rating.

Globus Medical (GMED): Needham & Company LLC lowered its price target to $100.00 from $117.00 and assigned a Buy rating.

Globus Medical (GMED): Wells Fargo & Company raised its price target to $100.00 from $99.00 and assigned an Overweight rating.

Grindr (GRND): The Goldman Sachs Group reiterated a Buy rating with a $20.00 price target.

Grupo Aeroportuario del Centro Norte (OMAB): Citigroup downgraded the stock to Neutral.

Grupo Aeroportuario Del Pacifico (PAC): Citigroup downgraded the stock to Neutral.

Gulfport Energy (GPOR): Truist Financial raised its price target to $192.00 from $186.00 and assigned a Hold rating.

GXO Logistics (GXO): Susquehanna raised its price target to $66.00 from $60.00 and assigned a Positive rating.

HA Sustainable Infrastructure Capital (HASI): Oppenheimer reiterated an Outperform rating.

Haemonetics (HAE): Barrington Research raised its price target to $145.00 from $140.00 and assigned an Outperform rating.

Haemonetics (HAE): Citigroup raised its price target to $149.00 from $123.00 and assigned a Buy rating.

Halozyme Therapeutics (HALO): Citizens Jmp raised its price target to $149.00 from $93.00 and assigned a Market Outperform rating.

Halozyme Therapeutics (HALO): Wells Fargo & Company raised its price target to $110.00 from $95.00 and assigned an Equal Weight rating.

Helios Technologies (HLIO): Robert W. Baird downgraded the stock to Neutral with a price target of $65.

Helios Towers (HTWS): Deutsche Bank Aktiengesellschaft raised its price target to GBX 290 from GBX 285 and assigned a Buy rating.

Hikma Pharmaceuticals (HIK): Deutsche Bank Aktiengesellschaft lowered its price target to $65.00 from $90.00 and assigned a Neutral rating.

HMH Holding (HMH): JP Morgan downgraded the stock to Neutral with a price target of $15.

Holley (HLLY): Canaccord Genuity Group lowered its price target to $5.00 from $7.00 and assigned a Buy rating.

Holley (HLLY): DA Davidson set a price target of $15.00 with a Neutral rating.

Honest (HNST): B. Riley Financial reiterated a Buy rating and updated its price target to $5.50 from $5.00.

Howden Joinery Group (HWDN): Deutsche Bank Aktiengesellschaft reiterated a Buy rating with a GBX 1,210 price target.

HubSpot (HUBS): Citigroup lowered its price target to $230.00 from $287.00 and assigned a Neutral rating.

Humana (HUM): Jefferies Financial Group reiterated a Buy rating with a $420.00 price target.

Humana (HUM): Raymond James Financial reiterated an Outperform rating.

Hut 8 (HUT): B. Riley Financial reiterated a Buy rating and updated its price target to $132.00 from $134.00.

Hyperliquid Strategies (PURR): Cantor Fitzgerald raised its price target to $35.00 from $34.30 and assigned an Overweight rating.

ICU Medical (ICUI): KeyCorp raised its price target to $189.00 from $187.00 and assigned an Overweight rating.

ICU Medical (ICUI): Piper Sandler raised its price target to $200.00 from $195.00 and assigned an Overweight rating.

IMAX (IMAX): Wedbush reiterated an Outperform rating with a $62.00 price target.

IMAX (IMAX): Wells Fargo & Company lowered its price target to $52.00 from $55.00 and assigned an Equal Weight rating.

indie Semiconductor (INDI): B. Riley Financial lowered its price target to $4.00 from $5.00 and assigned a Buy rating.

Ingredion (INGR): Stephens lowered its price target to $100.00 from $105.00 and assigned an Equal Weight rating.

Inovio Pharmaceuticals (INO): Jefferies Financial Group reiterated a Buy rating.

Insight Enterprises (NSIT): Canaccord Genuity Group raised its price target to $175.00 from $140.00 and assigned a Hold rating.

Inspired Entertainment (INSE): B. Riley Financial lowered its price target to $6.25 from $8.75 and assigned a Buy rating.

Inspired Entertainment (INSE): Citizens Jmp lowered its price target to $7.00 from $9.00 and assigned a Market Outperform rating.

Installed Building Products (IBP): Royal Bank Of Canada lowered its price target to $194.00 from $208.00 and assigned a Sector Perform rating.

Installed Building Products (IBP): The Goldman Sachs Group reiterated a Buy rating with a $261.00 price target.

Installed Building Products (IBP): Truist Financial raised its price target to $180.00 from $160.00 and assigned a Hold rating.

Insulet (PODD): Barclays raised its price target to $165.00 from $150.00 and assigned an Equal Weight rating.

International Business Machines (IBM): Evercore reiterated an Outperform rating.

International Business Machines (IBM): Susquehanna set a price target of $275.00.

International Flavors & Fragrances (IFF): Bank of America downgraded the stock to Underperform with a price target of $91.

International Flavors & Fragrances (IFF): Barclays lowered its price target to $103.00 from $105.00 and assigned an Overweight rating.

Interparfums (IPAR): Canaccord Genuity Group raised its price target to $154.00 from $151.00 and assigned a Buy rating.

Interparfums (IPAR): Jefferies Financial Group raised its price target to $156.00 from $145.00 and assigned a Buy rating.

Intrepid Potash (IPI): Susquehanna set a price target of $40.00.

IonQ (IONQ): Bank of America reiterated a Buy rating with a $50.00 price target.

IonQ (IONQ): Cantor Fitzgerald lowered its price target to $60.00 from $70.00 and assigned an Overweight rating.

IonQ (IONQ): Jefferies Financial Group lowered its price target to $65.00 from $80.00 and assigned a Buy rating.

IonQ (IONQ): Needham & Company LLC lowered its price target to $48.00 from $65.00 and assigned a Buy rating.

Iovance Biotherapeutics (IOVA): Barclays raised its price target to $19.00 from $18.00 and assigned an Overweight rating.

Iovance Biotherapeutics (IOVA): Citizens Jmp raised its price target to $12.00 from $8.00 and assigned a Market Outperform rating.

IREN (IREN): BTIG Research reiterated a Buy rating.

IREN (IREN): Cantor Fitzgerald lowered its price target to $47.00 from $99.00 and assigned an Overweight rating.

IREN (IREN): HC Wainwright lowered its price target to $56.00 from $74.00 and assigned a Buy rating.

IREN (IREN): The Goldman Sachs Group reiterated a Neutral rating with a $30.00 price target.

iRhythm Technologies (IRTC): BTIG Research lowered its price target to $170.00 from $185.00 and assigned a Buy rating.

iRhythm Technologies (IRTC): Canaccord Genuity Group raised its price target to $206.00 from $196.00 and assigned a Buy rating.

iRhythm Technologies (IRTC): Citigroup downgraded the stock to Neutral with a price target of $124.

iRhythm Technologies (IRTC): Needham & Company LLC lowered its price target to $165.00 from $194.00 and assigned a Buy rating.

iRhythm Technologies (IRTC): Piper Sandler lowered its price target to $150.00 from $160.00 and assigned an Overweight rating.

iRhythm Technologies (IRTC): Wells Fargo & Company lowered its price target to $135.00 from $150.00 and assigned an Overweight rating.

ITT (ITT): Citigroup lowered its price target to $251.00 from $267.00 and assigned a Buy rating.

Jack Henry & Associates (JKHY): DA Davidson raised its price target to $212.00 from $198.00 and assigned a Buy rating.

James Hardie Industries (JHX): Stephens lowered its price target to $33.00 from $34.00 and assigned an Overweight rating.

James Hardie Industries (JHX): Truist Financial lowered its price target to $37.00 from $40.00 and assigned a Buy rating.

Janux Therapeutics (JANX): Barclays raised its price target to $15.00 from $14.00 and assigned an Underweight rating.

Janux Therapeutics (JANX): Truist Financial raised its price target to $27.00 from $26.00 and assigned a Buy rating.

Janux Therapeutics (JANX): Wedbush raised its price target to $40.00 from $36.00 and assigned an Outperform rating.

JFrog (FROG): Canaccord Genuity Group raised its price target to $110.00 from $105.00 and assigned a Buy rating.

JFrog (FROG): Guggenheim raised its price target to $125.00 from $115.00 and assigned a Buy rating.

JFrog (FROG): KeyCorp raised its price target to $118.00 from $114.00 and assigned an Overweight rating.

JFrog (FROG): Piper Sandler raised its price target to $95.00 from $90.00 and assigned a Neutral rating.

JFrog (FROG): Royal Bank Of Canada raised its price target to $121.00 from $118.00 and assigned an Outperform rating.

JFrog (FROG): Truist Financial raised its price target to $120.00 from $115.00 and assigned a Buy rating.

JinkoSolar (JKS): UBS Group upgraded the stock to Buy with a price target of $17.

Karman (KRMN): Needham & Company LLC lowered its price target to $50.00 from $80.00 and assigned a Buy rating.

Karman (KRMN): Piper Sandler reiterated an Overweight rating and updated its price target to $60.00 from $59.00.

Keel Infrastructure (KEEL): The Goldman Sachs Group initiated coverage with a Neutral rating and a $2 price target.

Kimberly-Clark (KMB): Piper Sandler raised its price target to $137.00 from $118.00 and assigned an Overweight rating.

Kimberly-Clark (KMB): Wells Fargo & Company raised its price target to $110.00 from $100.00 and assigned an Equal Weight rating.

Knife River (KNF): DA Davidson set a price target of $66.00.

Kodiak AI (KDK): Needham & Company LLC lowered its price target to $4.00 and assigned a Buy rating.

Kodiak Gas Services (KGS): Jefferies Financial Group reiterated a Buy rating with a $53.00 price target.

Kontoor Brands (KTB): UBS Group lowered its price target to $125.00 from $136.00 and assigned a Buy rating.

Kratos Defense & Security Solutions (KTOS): BTIG Research lowered its price target to $65.00 from $104.00 and assigned a Buy rating.

Kura Sushi USA (KRUS): DA Davidson lowered its price target to $41.00 from $55.00 and assigned a Buy rating.

Kura Sushi USA (KRUS): TD Cowen lowered its price target to $38.00 from $51.00 and assigned a Hold rating.

Kura Sushi USA (KRUS): William Blair downgraded the stock to Market Perform.

Lamar Advertising (LAMR): Wells Fargo & Company reported a price-target increase and assigned a Market Perform rating.

Lemonade (LMND): Citizens Jmp lowered its price target to $75.00 from $80.00 and assigned a Market Outperform rating.

Lemonade (LMND): Piper Sandler lowered its price target to $47.00 from $51.00 and assigned a Neutral rating.

Lemonade (LMND): Truist Financial lowered its price target to $60.00 from $70.00 and assigned a Buy rating.

Liberty Media Corporation – Liberty Formula One Series C (FWONK): Wells Fargo & Company raised its price target to $113.00 from $96.00 and assigned an Equal Weight rating.

LifeStance Health Group (LFST): Canaccord Genuity Group raised its price target to $16.00 from $15.00 and assigned a Buy rating.

LifeStance Health Group (LFST): KeyCorp raised its price target to $17.00 from $15.00 and assigned an Overweight rating.

Live Nation Entertainment (LYV): Wells Fargo & Company lowered its price target to $221.00 from $222.00 and assigned an Overweight rating.

Lumen Technologies (LUMN): Citigroup lowered its price target to $5.50 from $8.25 and assigned a Neutral rating.

Lyft (LYFT): BMO Capital Markets reiterated a Market Perform rating.

Lyft (LYFT): Evercore set a price target of $23.00.

Lyft (LYFT): Raymond James Financial reiterated a Market Perform rating.

Lyft (LYFT): Rosenblatt Securities lowered its price target to $18.00 from $19.00 and assigned a Neutral rating.

Lyft (LYFT): Scotiabank lowered its price target to $16.00 from $17.00 and assigned a Sector Perform rating.

Lyft (LYFT): The Goldman Sachs Group reiterated a Buy rating with a $20.00 price target.

Lyft (LYFT): Truist Financial raised its price target to $18.00 from $16.00 and assigned a Hold rating.

MACOM Technology Solutions (MTSI): Truist Financial lowered its price target to $310.00 from $375.00 and assigned a Buy rating.

Madison Air Solutions (MAIR): Citigroup lowered its price target to $36.00 from $40.00 and assigned a Buy rating.

Madison Air Solutions (MAIR): Royal Bank Of Canada lowered its price target to $29.00 from $35.00 and assigned an Outperform rating.

Magnolia Oil & Gas (MGY): Truist Financial reiterated a Buy rating and updated its price target to $37.00 from $35.00.

Magnolia Oil & Gas (MGY): Wells Fargo & Company lowered its price target to $29.00 from $30.00 and assigned an Equal Weight rating.

Magnum Ice Cream (MICC): Morgan Stanley downgraded the stock to Equal Weight.

Malibu Boats (MBUU): B. Riley Financial reiterated a Neutral rating and updated its price target to $22.00 from $30.00.

Man Group (EMG): Deutsche Bank Aktiengesellschaft lowered its price target to GBX 355 from GBX 365 and assigned a Hold rating.

Manitowoc (MTW): Barclays raised its price target to $20.00 from $16.00 and assigned an Underweight rating.

MannKind (MNKD): Cantor Fitzgerald raised its price target to $10.00 from $8.00 and assigned an Overweight rating.

MannKind (MNKD): Royal Bank Of Canada raised its price target to $5.00 from $4.75 and assigned a Sector Perform rating.

Marks and Spencer Group (MKS): Deutsche Bank Aktiengesellschaft raised its price target to GBX 470 from GBX 435 and assigned a Buy rating.

Marriott International (MAR): Citigroup raised its price target to $450.00 from $365.00 and assigned a Neutral rating.

Martin Marietta Materials (MLM): Citigroup raised its price target to $641.00 from $610.00 and assigned a Buy rating.

Martin Marietta Materials (MLM): Raymond James Financial reiterated an Outperform rating with a $620.00 price target.

Martin Marietta Materials (MLM): Royal Bank Of Canada lowered its price target to $520.00 from $530.00 and assigned a Sector Perform rating.

MasterBrand (MBC): DA Davidson lowered its price target to $8.00 from $10.00 and assigned a Neutral rating.

Mattel (MAT): Bank of America reiterated a Buy rating with a $21.00 price target.

Mattel (MAT): Citigroup lowered its price target to $15.00 from $17.00 and assigned a Neutral rating.

McDonald’s (MCD): Argus raised its price target to $320.00 from $310.00 and assigned a Buy rating.

MGE Energy (MGEE): Subscribe to MarketBeat All Access to unlock brokerage rankings upgraded the stock to Buy with a price target of $87.00.

MGIC Investment (MTG): Barclays raised its price target to $30.00 from $29.00 and assigned an Equal Weight rating.

Microchip Technology (MCHP): B. Riley Financial lowered its price target to $85.00 from $98.00 and assigned a Buy rating.

Microchip Technology (MCHP): Cantor Fitzgerald lowered its price target to $100.00 from $125.00 and assigned an Overweight rating.

Microchip Technology (MCHP): Citigroup lowered its price target to $75.00 from $95.00 and assigned a Buy rating.

Microchip Technology (MCHP): Jefferies Financial Group lowered its price target to $85.00 from $100.00 and assigned a Buy rating.

Microchip Technology (MCHP): KeyCorp lowered its price target to $120.00 from $135.00 and assigned an Overweight rating.

Microchip Technology (MCHP): Needham & Company LLC lowered its price target to $85.00 from $120.00 and assigned a Buy rating.

Microchip Technology (MCHP): Rosenblatt Securities lowered its price target to $115.00 from $120.00 and assigned a Buy rating.

Microchip Technology (MCHP): Susquehanna lowered its price target to $100.00 from $120.00 and assigned a Positive rating.

Microchip Technology (MCHP): Truist Financial lowered its price target to $62.00 from $90.00 and assigned a Hold rating.

Microchip Technology (MCHP): Wells Fargo & Company lowered its price target to $70.00 from $80.00 and assigned an Equal Weight rating.

Microsoft (MSFT): Roth Capital initiated coverage with a Buy rating.

Middleby (MIDD): Canaccord Genuity Group raised its price target to $160.00 from $152.00 and assigned a Buy rating.

Miller Industries (MLR): DA Davidson lowered its price target to $54.00 from $64.00 and assigned a Buy rating.

MKS (MKSI): Citigroup lowered its price target to $350.00 from $430.00 and assigned a Buy rating.

MKS (MKSI): Wells Fargo & Company lowered its price target to $195.00 from $285.00 and assigned an Equal Weight rating.

MNTN (MNTN): UBS Group reiterated a Buy rating with a $9.00 price target.

Mobia Medical (MOBI): BTIG Research reiterated an Overweight rating and updated its price target to $95.00 from $92.00.

Molson Coors Beverage (TAP): Needham & Company LLC lowered its price target to $46.00 from $50.00 and assigned a Buy rating.

Molson Coors Beverage (TAP): Piper Sandler lowered its price target to $43.00 from $44.00 and assigned a Neutral rating.

Molson Coors Beverage (TAP): Wells Fargo & Company downgraded the stock to Underweight with a price target of $36.00.

Molten Ventures (GROW): Deutsche Bank Aktiengesellschaft reiterated a Buy rating with a GBX 877 price target.

Monster Beverage (MNST): Jefferies Financial Group reiterated a Buy rating with a $55.00 price target.

Monster Beverage (MNST): Piper Sandler raised its price target to $53.00 from $50.50 and assigned an Overweight rating.

Monster Beverage (MNST): The Goldman Sachs Group reiterated a Buy rating with a $55.00 price target.

Monster Beverage (MNST): UBS Group reiterated a Neutral rating and updated its price target to $50.00 from $49.00.

Monster Beverage (MNST): Wells Fargo & Company raised its price target to $52.00 from $50.00 and assigned an Overweight rating.

Monte Rosa Therapeutics (GLUE): Wells Fargo & Company lowered its price target to $25.00 from $27.00 and assigned an Overweight rating.

Montrose Environmental Group (ONT): Barclays raised its price target to $19.00 from $15.00 and assigned an Equal Weight rating.

MoonLake Immunotherapeutics (MLTX): Chardan Capital initiated coverage with a Buy rating and a $57 price target.

Morgan Sindall Group (MGNS): Deutsche Bank Aktiengesellschaft reiterated a Buy rating with a GBX 6,200 price target.

Mueller Water Products (MWA): Barclays lowered its price target to $24.00 from $25.00 and assigned an Underweight rating.

N-able (NABL): Royal Bank Of Canada raised its price target to $5.00 from $4.00 and assigned a Sector Perform rating.

N-able (NABL): Scotiabank raised its price target to $5.45 from $3.65 and assigned a Sector Perform rating.

Natera (NTRA): JPMorgan Chase & Co. lowered its price target to $405.00 from $460.00 and assigned an Overweight rating.

Natera (NTRA): Piper Sandler reiterated an Overweight rating with a $363.50 price target.

NerdWallet (NRDS): Truist Financial lowered its price target to $12.00 from $15.00 and assigned a Buy rating.

NerdWallet (NRDS): William Blair downgraded the stock to Market Perform.

NetScout Systems (NTCT): Royal Bank Of Canada lowered its price target to $35.00 from $43.00 and assigned a Sector Perform rating.

Neuronetics (STIM): B. Riley Financial raised its price target to $6.00 from $5.00 and assigned a Buy rating.

Nexstar Media Group (NXST): Wells Fargo & Company raised its price target to $250.00 from $249.00 and assigned an Overweight rating.

Next 15 Group (NFG): Berenberg Bank lowered its price target to GBX 475 from GBX 510 and assigned a Buy rating.

Next 15 Group (NFG): Deutsche Bank Aktiengesellschaft reiterated a Buy rating with a GBX 473 price target.

Nextdoor (NXDR): Citigroup lowered its price target to $2.65 from $2.85 and assigned a Neutral rating.

Niagen Bioscience (NAGE): Canaccord Genuity Group lowered its price target to $7.00 from $9.00 and assigned a Buy rating.

Niagen Bioscience (NAGE): Subscribe to MarketBeat All Access to unlock brokerage rankings lowered its price target to $6.00 from $8.50 and assigned a Buy rating.

NIKE (NKE): Royal Bank Of Canada lowered its price target to $39.00 from $40.00 and assigned a Sector Perform rating.

NMI (NMIH): Barclays lowered its price target to $42.00 from $43.00 and assigned an Equal Weight rating.

NNN REIT (NNN): Citigroup lowered its price target to $44.00 from $46.00 and assigned a Neutral rating.

Northwest Natural Gas (NWN): BTIG Research reiterated a Buy rating with a $59.00 price target.

Northwest Natural Gas (NWN): Wells Fargo & Company raised its price target to $50.00 from $49.00 and assigned an Equal Weight rating.

Nova (NVMI): Barclays lowered its price target to $500.00 from $600.00 and assigned an Overweight rating.

Nova (NVMI): Jefferies Financial Group lowered its price target to $460.00 from $600.00 and assigned a Buy rating.

Novagold Resources (NG): Citigroup initiated coverage with a Buy rating and a $12.50 price target.

NovaGold Resources (NG): Citigroup resumed coverage with a Buy rating and a $12.50 price target.

Novavax (NVAX): B. Riley Financial reiterated a Buy rating and updated its price target to $16.00 from $18.00.

NuScale Power (SMR): Canaccord Genuity Group lowered its price target to $11.00 from $15.00 and assigned a Buy rating.

NuScale Power (SMR): Cantor Fitzgerald lowered its price target to $15.00 from $20.00 and assigned an Overweight rating.

NuScale Power (SMR): Citigroup lowered its price target to $3.50 from $4.00 and assigned a Sell rating.

NuScale Power (SMR): Royal Bank Of Canada lowered its price target to $5.00 from $7.00 and assigned a Sector Perform rating.

NuScale Power (SMR): The Goldman Sachs Group reiterated a Neutral rating with a $4.00 price target.

Odyssey Therapeutics (ODTX): H.C. Wainwright resumed coverage with a Buy rating and a $40 price target.

Old Dominion Freight Line (ODFL): Susquehanna lowered its price target to $40.00 and assigned a Buy rating.

Omada Health (OMDA): Barclays lowered its price target to $22.00 from $24.00 and assigned an Overweight rating.

Omada Health (OMDA): Wells Fargo & Company lowered its price target to $19.00 from $22.00 and assigned an Equal Weight rating.

Oncology Institute (STLN): B. Riley Financial reiterated a Buy rating and updated its price target to $10.00 from $11.00.

Oncology Institute (STLN): BTIG Research raised its price target to $10.00 from $9.00 and assigned a Buy rating.

Open Text (OTEX): Barclays raised its price target to $29.00 from $27.00 and assigned an Equal Weight rating.

Ormat Technologies (ORA): Barclays lowered its price target to $113.00 from $122.00 and assigned an Overweight rating.

Ormat Technologies (ORA): Oppenheimer lowered its price target to $130.00 from $145.00 and assigned an Outperform rating.

Ormat Technologies (ORA): Sanford C. Bernstein reiterated a Market Perform rating with a $112.00 price target.

Oscar Health (OSCR): Piper Sandler lowered its price target to $45.00 from $48.00 and assigned an Overweight rating.

Palatin Technologies (PTN): H.C. Wainwright resumed coverage with a Buy rating and a $12 price target.

Palomar (PLMR): Piper Sandler raised its price target to $174.00 from $165.00 and assigned an Overweight rating.

Palvella Therapeutics (PVLA): Oppenheimer raised its price target to $232.00 from $210.00 and assigned an Outperform rating.

PAR Technology (PAR): Needham & Company LLC raised its price target to $30.00 from $25.00 and assigned a Buy rating.

Paycom Software (PAYC): Citigroup lowered its price target to $264.00 from $279.00 and assigned a Neutral rating.

Paylocity (PCTY): Barclays raised its price target to $176.00 from $162.00 and assigned an Equal Weight rating.

Paylocity (PCTY): BTIG Research raised its price target to $210.00 from $200.00 and assigned a Buy rating.

Paylocity (PCTY): Citizens Jmp raised its price target to $200.00 from $180.00 and assigned a Market Outperform rating.

PDF Solutions (PDFS): DA Davidson lowered its price target to $60.00 from $68.00 and assigned a Buy rating.

PDF Solutions (PDFS): Wells Fargo & Company lowered its price target to $39.00 from $50.00 and assigned an Equal Weight rating.

Peloton Interactive (PTON): Telsey Advisory Group reiterated a Market Perform rating.

PENN Entertainment (PENN): Needham & Company LLC reiterated a Hold rating.

PENN Entertainment (PENN): The Goldman Sachs Group reiterated a Buy rating with a $21.00 price target.

PENN Entertainment (PENN): Wells Fargo & Company raised its price target to $23.00 from $22.00 and assigned an Equal Weight rating.

Performance Food Group (PFGC): Citigroup raised its price target to $141.00 from $127.00 and assigned a Buy rating.

Permian Resources (PR): Wells Fargo & Company lowered its price target to $27.00 from $28.00 and assigned an Overweight rating.

Pfizer (PFE): DZ Bank downgraded the stock to Hold.

Pfizer (PFE): FBN Securities set a price target of $34.00.

Pfizer (PFE): Subscribe to MarketBeat All Access to unlock brokerage rankings raised its price target to $34.00 from $33.00 and assigned a Buy rating.

Planet Fitness (PLNT): KeyCorp raised its price target to $68.00 from $65.00 and assigned an Overweight rating.

Planet Fitness (PLNT): Royal Bank Of Canada raised its price target to $70.00 from $60.00 and assigned an Outperform rating.

Planet Fitness (PLNT): Wells Fargo & Company raised its price target to $75.00 from $65.00 and assigned an Overweight rating.

Playtika (PLTK): Wedbush lowered its price target to $3.00 from $4.00 and assigned a Neutral rating.

Portillo’s (PTLO): DA Davidson raised its price target to $7.00 from $5.00 and assigned a Neutral rating.

Portillo’s (PTLO): Stephens raised its price target to $7.00 from $5.00 and assigned an Equal Weight rating.

Prestige Consumer Healthcare (PBH): Canaccord Genuity Group lowered its price target to $70.00 from $72.00 and assigned a Buy rating.

Primoris Services (PRIM): Mizuho set a price target of $111.00.

Primoris Services (PRIM): Wells Fargo & Company lowered its price target to $64.00 from $85.00 and assigned an Equal Weight rating.

Privia Health Group (PRVA): Canaccord Genuity Group raised its price target to $33.00 from $32.00 and assigned a Buy rating.

Privia Health Group (PRVA): Piper Sandler raised its price target to $38.00 from $36.00 and assigned an Overweight rating.

PROCEPT BioRobotics (PRCT): Truist Financial raised its price target to $24.00 from $21.00 and assigned a Hold rating.

Prospect Capital (PSEC): Wells Fargo & Company lowered its price target to $1.50 from $2.00 and assigned an Underweight rating.

Protagonist Therapeutics (PTGX): HC Wainwright raised its price target to $221.00 from $170.00 and assigned a Buy rating.

Pulse Biosciences (PLSE): Canaccord Genuity Group raised its price target to $74.00 from $58.00 and assigned a Buy rating.

Pulse Biosciences (PLSE): Mizuho set a price target of $65.00.

Pulse Biosciences (PLSE): Needham & Company LLC raised its price target to $64.00 from $58.00 and assigned a Buy rating.

Pyxis Oncology (PYXS): Royal Bank Of Canada raised its price target to $7.00 from $6.00 and assigned an Outperform rating.

Pyxis Oncology (PYXS): Wedbush lowered its price target to $7.00 from $8.00 and assigned an Outperform rating.

Qnity Electronics (Q): Barclays raised its price target to $216.00 from $211.00 and assigned an Overweight rating.

Quantinuum (QNT): Cantor Fitzgerald lowered its price target to $55.00 from $90.00 and assigned an Overweight rating.

Quantinuum (QNT): Jefferies Financial Group lowered its price target to $65.00 from $85.00 and assigned a Buy rating.

Quantinuum (QNT): JPMorgan Chase & Co. lowered its price target to $80.00 from $97.00 and assigned an Overweight rating.

Quantinuum (QNT): Needham & Company LLC lowered its price target to $60.00 from $100.00 and assigned a Buy rating.

Radian Group (RDN): Barclays raised its price target to $37.00 from $36.00 and assigned an Equal Weight rating.

Ralph Lauren (RL): Barclays raised its price target to $473.00 from $463.00 and assigned an Overweight rating.

Rapid7 (RPD): Susquehanna raised its price target to $16.00 from $15.00 and assigned a Neutral rating.

Rayonier (RYN): Royal Bank Of Canada raised its price target to $22.00 from $20.00 and assigned a Sector Perform rating.

Redwire (RDW): B. Riley Financial lowered its price target to $14.00 from $15.00 and assigned a Buy rating.

Redwire (RDW): Canaccord Genuity Group lowered its price target to $13.00 from $15.00 and assigned a Buy rating.

Redwire (RDW): Piper Sandler lowered its price target to $8.00 from $11.00 and assigned a Neutral rating.

Reformation (REF): BTIG Research raised its price target to $21.00 from $20.00 and assigned a Buy rating.

Reformation (REF): Royal Bank Of Canada raised its price target to $21.00 from $18.00 and assigned an Outperform rating.

REGENXBIO (RGNX): Mizuho set a price target of $18.00.

REGENXBIO (RGNX): UBS Group reiterated a Positive rating.

Reliance (RS): Citigroup raised its price target to $460.00 from $420.00 and assigned a Neutral rating.

Revolution Medicines (RVMD): HC Wainwright raised its price target to $350.00 from $280.00 and assigned a Buy rating.

RH (RH): Citigroup lowered its price target to $155.00 from $166.00 and assigned a Neutral rating.

Rigel Pharmaceuticals (RIGL): Cantor Fitzgerald raised its price target to $47.00 from $43.00 and assigned a Neutral rating.

Rivian Automotive (RIVN): DA Davidson lowered its price target to $15.00 from $17.00 and assigned a Neutral rating.

Rockwell Automation (ROK): Citigroup lowered its price target to $504.00 from $536.00 and assigned a Buy rating.

Rockwell Automation (ROK): Stephens lowered its price target to $500.00 from $550.00 and assigned an Overweight rating.

Royal Gold (RGLD): Raymond James Financial set a price target of $337.00.

RS Group (RS1): Deutsche Bank Aktiengesellschaft raised its price target to GBX 885 from GBX 850 and assigned a Buy rating.

Sarepta Therapeutics (SRPT): Robert W. Baird set a price target of $18.00.

Sarepta Therapeutics (SRPT): Royal Bank Of Canada raised its price target to $18.00 from $17.00 and assigned a Sector Perform rating.

Schneider National (SNDR): Susquehanna lowered its price target to $34.00 from $36.00 and assigned a Neutral rating.

Seaport Entertainment Gr (SEG): JonesTrading lowered its price target to $30.00 from $36.00 and assigned a Buy rating.

Septerna (SEPN): Guggenheim raised its price target to $65.00 from $51.00 and assigned a Buy rating.

Serve Robotics (SERV): Oppenheimer reiterated an Outperform rating.

Shift4 Payments (FOUR): B. Riley Financial reiterated a Buy rating and updated its price target to $77.00 from $94.00.

Shift4 Payments (FOUR): Bank of America reiterated a Neutral rating.

Shift4 Payments (FOUR): Royal Bank Of Canada lowered its price target to $49.00 from $67.00 and assigned an Outperform rating.

Shift4 Payments (FOUR): Susquehanna lowered its price target to $56.00 from $63.00 and assigned a Positive rating.

Shift4 Payments (FOUR): Wells Fargo & Company lowered its price target to $46.00 from $59.00 and assigned an Overweight rating.

SiTime (SITM): Barclays initiated coverage with a Buy rating.

SiTime (SITM): Citigroup downgraded the stock to Neutral.

SiTime (SITM): Guggenheim initiated coverage with a Buy rating.

SiTime (SITM): Raymond James Financial upgraded the stock to Strong-Buy.

SiTime (SITM): Roth Capital initiated coverage with a Buy rating.

SiTime (SITM): Seaport Research Partners upgraded the stock to Buy with a price target of $425.

SiTime (SITM): Wells Fargo & Company downgraded the stock to Underweight.

Six Flags Entertainment (FUN): Barclays lowered its price target to $13.00 from $22.00 and assigned an Overweight rating.

Six Flags Entertainment (FUN): The Goldman Sachs Group reiterated a Neutral rating with a $9.00 price target.

Sixth Street Specialty Lending (TSLX): B. Riley Financial reiterated a Buy rating and updated its price target to $19.00 from $20.00.

Skyward Specialty Insurance Group (SKWD): Barclays raised its price target to $71.00 from $68.00 and assigned an Overweight rating.

SLR Investment (SLRC): B. Riley Financial lowered its price target to $13.00 from $14.00 and assigned a Buy rating.

Snap (SNAP): Citigroup lowered its price target to $6.00 from $6.75 and assigned a Neutral rating.

Sociedad Quimica y Minera (SQM): JPMorgan Chase & Co. upgraded the stock to Overweight with a price target of $71.

SolarEdge Technologies (SEDG): Royal Bank Of Canada lowered its price target to $25.00 from $30.00 and assigned a Sector Perform rating.

Solaris Energy Infrastructure (SEI): Barclays raised its price target to $140.00 from $116.00 and assigned an Overweight rating.

Solaris Energy Infrastructure (SEI): Raymond James Financial upgraded the stock to Strong-Buy with a price target of $113.00.

Solaris Energy Infrastructure (SEI): The Goldman Sachs Group set a price target of $113.00.

Solaris Energy Infrastructure (SEI): Wells Fargo & Company lowered its price target to $65.00 from $72.00 and assigned an Overweight rating.

Solventum (SOLV): BTIG Research reiterated a Buy rating.

Solventum (SOLV): Piper Sandler reiterated an Overweight rating and updated its price target to $110.00 from $105.00.

Solventum (SOLV): Wells Fargo & Company raised its price target to $95.00 from $89.00 and assigned an Equal Weight rating.

Sonida Senior Living (SNDA): Citizens Jmp lowered its price target to $45.00 from $50.00 and assigned a Market Outperform rating.

SoundHound AI (SOUN): Cantor Fitzgerald lowered its price target to $10.00 from $15.00 and assigned an Overweight rating.

SoundHound AI (SOUN): DA Davidson lowered its price target to $5.00 from $10.00 and assigned a Buy rating.

SoundHound AI (SOUN): Oppenheimer reiterated a Market Perform rating.

Sphere Entertainment (SPHR): BTIG Research lowered its price target to $145.00 from $160.00 and assigned a Buy rating.

Sphere Entertainment (SPHR): Guggenheim lowered its price target to $175.00 from $180.00 and assigned a Buy rating.

Sphere Entertainment (SPHR): Susquehanna reiterated a Positive rating with a $156.00 price target.

Sphere Entertainment (SPHR): The Goldman Sachs Group reiterated a Buy rating with a $150.00 price target.

StandardAero (SARO): UBS Group raised its price target to $34.00 from $32.00 and assigned a Buy rating.

Starbucks (SBUX): UBS Group raised its price target to $110.00 from $105.00 and assigned a Neutral rating.

StepStone Group (STEP): Barclays raised its price target to $65.00 from $62.00 and assigned an Overweight rating.

StepStone Group (STEP): Royal Bank Of Canada raised its price target to $68.00 from $65.00 and assigned an Outperform rating.

STERIS (STE): KeyCorp raised its price target to $284.00 from $269.00 and assigned an Overweight rating.

Steven Madden (SHOO): Jefferies Financial Group upgraded the stock to Hold with a price target of $36.

Strategic Education (STRA): Barrington Research downgraded the stock to Market Perform.

Strategic Education (STRA): BMO Capital Markets downgraded the stock to Market Perform with a price target of $66.

Strategic Education (STRA): William Blair downgraded the stock to Market Perform.

Strive (ASST): HC Wainwright lowered its price target to $40.00 from $42.00 and assigned a Buy rating.

Sunrun (RUN): Royal Bank Of Canada lowered its price target to $10.00 from $11.00 and assigned an Outperform rating.

Sweetgreen (SG): Citigroup raised its price target to $15.00 from $13.00 and assigned a Buy rating.

Sweetgreen (SG): DA Davidson raised its price target to $12.00 from $5.50 and assigned a Neutral rating.

Sweetgreen (SG): KeyCorp raised its price target to $13.00 from $12.00 and assigned an Overweight rating.

Sweetgreen (SG): Oppenheimer raised its price target to $14.00 from $8.50 and assigned an Outperform rating.

Sweetgreen (SG): TD Cowen raised its price target to $11.00 from $9.00 and assigned a Hold rating.

Sweetgreen (SG): Wells Fargo & Company raised its price target to $14.00 from $11.00 and assigned an Overweight rating.

Tandem Diabetes Care (TNDM): Barclays raised its price target to $20.00 from $18.00 and assigned an Equal Weight rating.

Tandem Diabetes Care (TNDM): Mizuho set a price target of $20.00.

Tandem Diabetes Care (TNDM): Wells Fargo & Company lowered its price target to $25.00 from $27.00 and assigned an Overweight rating.

Tapestry (TPR): Barclays raised its price target to $195.00 from $185.00 and assigned an Overweight rating.

Tapestry (TPR): Wells Fargo & Company raised its price target to $155.00 from $150.00 and assigned an Overweight rating.

Targa Resources (TRGP): Citigroup raised its price target to $338.00 from $325.00 and assigned a Buy rating.

Targa Resources (TRGP): Jefferies Financial Group lowered its price target to $311.00 from $326.00 and assigned a Buy rating.

Teleflex (TFX): Mizuho set a price target of $160.00.

Teleflex (TFX): Royal Bank Of Canada raised its price target to $175.00 from $155.00 and assigned an Outperform rating.

Teleflex (TFX): Wells Fargo & Company raised its price target to $167.00 from $138.00 and assigned an Equal Weight rating.

Tenaris (TS): Barclays raised its price target to $88.00 from $80.00 and assigned an Overweight rating.

Teradata (TDC): Barclays raised its price target to $28.00 from $27.00 and assigned an Underweight rating.

TeraWulf (WULF): Northland Securities set a price target of $22.50.

Ternium (TX): Scotiabank raised its price target to $57.00 from $40.00 and assigned a Sector Perform rating.

Texas Roadhouse (TXRH): Bank of America raised its price target to $227.00 from $225.00 and assigned a Buy rating.

Texas Roadhouse (TXRH): BMO Capital Markets reiterated a Market Perform rating with a $190.00 price target.

Texas Roadhouse (TXRH): BTIG Research reiterated a Buy rating.

Texas Roadhouse (TXRH): Citigroup raised its price target to $195.00 from $189.00 and assigned a Neutral rating.

Texas Roadhouse (TXRH): Royal Bank Of Canada lowered its price target to $215.00 from $220.00 and assigned an Outperform rating.

Texas Roadhouse (TXRH): TD Cowen raised its price target to $213.00 from $195.00 and assigned a Buy rating.

Texas Roadhouse (TXRH): Wells Fargo & Company lowered its price target to $220.00 from $230.00 and assigned an Overweight rating.

The Hanover Insurance Group (THG): Jefferies Financial Group set a price target of $248.00.

The Hanover Insurance Group (THG): Keefe, Bruyette & Woods reiterated a Market Perform rating.

The Pennant Group (PNTG): Royal Bank Of Canada raised its price target to $48.00 from $44.00 and assigned an Outperform rating.

Trainline (TRN): Berenberg Bank reiterated a Buy rating with a GBX 350 price target.

TransMedics Group (TMDX): Canaccord Genuity Group raised its price target to $120.00 from $95.00 and assigned a Buy rating.

TransMedics Group (TMDX): Needham & Company LLC raised its price target to $110.00 from $106.00 and assigned a Buy rating.

Trinity Capital (TRIN): B. Riley Financial reiterated a Buy rating and updated its price target to $20.00 from $19.00.

TripAdvisor (TRIP): B. Riley Financial lowered its price target to $8.50 from $12.50 and assigned a Neutral rating.

TripAdvisor (TRIP): Barclays lowered its price target to $8.00 from $9.00 and assigned an Underweight rating.

TripAdvisor (TRIP): Cantor Fitzgerald lowered its price target to $6.00 from $8.00 and assigned an Underweight rating.

TripAdvisor (TRIP): UBS Group lowered its price target to $9.00 from $10.00 and assigned a Neutral rating.

TSS (TSSI): Needham & Company LLC lowered its price target to $9.00 from $13.00 and assigned a Buy rating.

Turtle Beach (TBCH): B. Riley Financial downgraded the stock to Neutral with a price target of $17.00.

U.S. Physical Therapy (USPH): Barrington Research raised its price target to $110.00 from $98.00 and assigned an Outperform rating.

Ulta Beauty (ULTA): Citigroup raised its price target to $685.00 from $580.00 and assigned a Neutral rating.

Unilever (ULVR): Deutsche Bank Aktiengesellschaft raised its price target to GBX 5,300 from GBX 5,150 and assigned a Hold rating.

United Parks & Resorts (PRKS): Citigroup raised its price target to $39.00 from $34.00 and assigned a Neutral rating.

United Parks & Resorts (PRKS): The Goldman Sachs Group reiterated a Neutral rating with a $39.00 price target.

Unity Software (U): Citigroup raised its price target to $59.00 from $48.00 and assigned a Buy rating.

Unity Software (U): Citizens Jmp raised its price target to $70.00 from $45.00 and assigned a Market Outperform rating.

Unity Software (U): Needham & Company LLC raised its price target to $70.00 from $54.00 and assigned a Buy rating.

Unity Software (U): Oppenheimer reiterated an Outperform rating and updated its price target to $64.00 from $47.00.

Unity Software (U): The Goldman Sachs Group reiterated a Neutral rating with a $62.00 price target.

Unity Software (U): UBS Group reiterated an Outperform rating.

Unity Software (U): UBS Group raised its price target to $56.00 from $49.00 and assigned a Neutral rating.

Unity Software (U): Wedbush raised its price target to $63.00 from $55.00 and assigned an Outperform rating.

Unity Software (U): Wells Fargo & Company raised its price target to $64.00 from $53.00 and assigned an Overweight rating.

Unusual Machines (UMAC): Needham & Company LLC lowered its price target to $22.00 from $40.00 and assigned a Buy rating.

US Foods (USFD): BTIG Research reiterated a Buy rating with a $120.00 price target.

USA Today (TDAY): Citigroup upgraded the stock to Buy with a price target of $8.95.

USA Today (TDAY): Rosenblatt Securities raised its price target to $11.00 from $10.00 and assigned a Buy rating.

Veeco Instruments (VECO): Citigroup lowered its price target to $55.00 from $63.00 and assigned a Buy rating.

Veeva Systems (VEEV): Jefferies Financial Group raised its price target to $375.00 from $295.00 and assigned a Buy rating.

Veeva Systems (VEEV): Needham & Company LLC raised its price target to $360.00 from $310.00 and assigned a Buy rating.

Veeva Systems (VEEV): Royal Bank Of Canada raised its price target to $365.00 from $325.00 and assigned an Outperform rating.

Veeva Systems (VEEV): UBS Group raised its price target to $325.00 from $290.00 and assigned a Neutral rating.

Vera Therapeutics (VERA): Guggenheim lowered its price target to $66.00 from $76.00 and assigned a Buy rating.

Vera Therapeutics (VERA): HC Wainwright lowered its price target to $75.00 from $90.00 and assigned a Buy rating.

Vera Therapeutics (VERA): Raymond James Financial set a price target of $87.00.

Vera Therapeutics (VERA): Wedbush lowered its price target to $29.00 from $34.00 and assigned a Neutral rating.

Verastem (VSTM): HC Wainwright raised its price target to $20.00 from $18.00 and assigned a Buy rating.

Verastem (VSTM): Royal Bank Of Canada lowered its price target to $18.00 from $19.00 and assigned an Outperform rating.

Vericel (VCEL): HC Wainwright raised its price target to $75.00 from $72.00 and assigned a Buy rating.

Vericel (VCEL): Truist Financial set a price target of $65.00.

Verisk Analytics (VRSK): Barclays raised its price target to $250.00 from $225.00 and assigned an Overweight rating.

Verisk Analytics (VRSK): Wells Fargo & Company raised its price target to $265.00 from $260.00 and assigned an Overweight rating.

Viasat (VSAT): Raymond James Financial reiterated an Outperform rating with a $95.00 price target.

Victory Capital (VCTR): Barclays raised its price target to $126.00 from $121.00 and assigned an Equal Weight rating.

Vistra (VST): Sanford C. Bernstein reiterated an Outperform rating with a $181.00 price target.

Vontier (VNT): Citigroup raised its price target to $47.00 from $44.00 and assigned a Buy rating.

Vontier (VNT): KeyCorp raised its price target to $43.00 from $40.00 and assigned an Overweight rating.

VSE (VSEC): Royal Bank Of Canada raised its price target to $225.00 from $220.00 and assigned an Outperform rating.

Warby Parker (WRBY): Citizens Jmp raised its price target to $40.00 from $29.00 and assigned a Market Outperform rating.

Warby Parker (WRBY): The Goldman Sachs Group reiterated a Buy rating with a $32.00 price target.

Warby Parker (WRBY): UBS Group raised its price target to $32.00 from $28.00 and assigned a Neutral rating.

Watts Water Technologies (WTS): Barclays lowered its price target to $424.00 from $425.00 and assigned an Overweight rating.

Watts Water Technologies (WTS): Royal Bank Of Canada lowered its price target to $397.00 from $417.00 and assigned a Sector Perform rating.

WBI (WBI): Barclays lowered its price target to $33.00 from $34.00 and assigned an Overweight rating.

Wendy’s (WEN): BMO Capital Markets reiterated a Market Perform rating.

Wendy’s (WEN): Citigroup raised its price target to $8.00 from $6.75 and assigned a Neutral rating.

Wendy’s (WEN): Stephens raised its price target to $8.00 from $7.00 and assigned an Equal Weight rating.

Westlake (WLK): Citigroup raised its price target to $70.00 from $67.00 and assigned a Neutral rating.

Westrock Coffee (WEST): Telsey Advisory Group set a price target of $13.00.

Wheaton Precious Metals (WPM): Raymond James Financial reiterated an Outperform rating with a $180.00 price target.

Williams-Sonoma (WSM): Citigroup raised its price target to $275.00 from $252.00 and assigned a Neutral rating.

WillScot (WSC): Bank of America reiterated a Buy rating with a $26.00 price target.

WillScot (WSC): Jefferies Financial Group reiterated a Hold rating with a $20.00 price target.

WillScot (WSC): Oppenheimer lowered its price target to $26.00 from $29.00 and assigned an Outperform rating.

Wynn Resorts (WYNN): Barclays lowered its price target to $120.00 from $128.00 and assigned an Overweight rating.

Wynn Resorts (WYNN): Stifel Nicolaus set a price target of $110.00.

Wynn Resorts (WYNN): Susquehanna reiterated a Positive rating with a $95.00 price target.

Wynn Resorts (WYNN): The Goldman Sachs Group reiterated a Buy rating with a $93.00 price target.

Wynn Resorts (WYNN): Wells Fargo & Company lowered its price target to $122.00 from $125.00 and assigned an Overweight rating.

Xeris Biopharma (XERS): HC Wainwright raised its price target to $18.00 from $10.00 and assigned a Buy rating.

Xeris Biopharma (XERS): Oppenheimer reiterated an Outperform rating and updated its price target to $21.00 from $18.00.

Xeris Biopharma (XERS): Piper Sandler reiterated a Neutral rating and updated its price target to $12.00 from $8.00.

Yarrow Bioscience (YARW): Guggenheim initiated coverage with a Buy rating and a $60 price target.

Yelp (YELP): The Goldman Sachs Group reiterated a Neutral rating with a $23.00 price target.

Yelp (YELP): UBS Group reiterated a Neutral rating.

Zillow Group (ZG): Susquehanna lowered its price target to $32.00 from $38.00 and assigned a Neutral rating.

Zoetis (ZTS): Jefferies Financial Group raised its price target to $85.00 from $83.00.

Keep researching

Related research

Mar 6, 2025

How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business

Oct 24, 2023

STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)

Oct 23, 2023

Bank of Canada Looks to Pause rates as Recession Looms

Nov 6, 2026

American Analyst Updates: Nov 5th, 2026

Nov 5, 2026

American Analyst Updates: Nov 4th, 2026

Nov 3, 2026

American Analyst Updates: Nov 3rd, 2026

A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.

Read a sample →